Episurf Medical converts SEK 37.5M convertibles to 833.8M Class B shares
The conversion increases share capital by SEK 8.3M and dilutes shares by 12.03%.
See the latest news and media coverage for Episurf Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of personalized orthopedic implants
episurf.comLast updated
In short: Episurf Medical aggressively pivoted into the real estate sector through multi-billion SEK acquisitions while reviewing its medtech operations.
The conversion increases share capital by SEK 8.3M and dilutes shares by 12.03%.
The deal includes about twenty properties valued at SEK 647 million, 52,000 sqm and SEK 56.9 million rent; closing expected Q4 2026; financed by B-share issue and bank loans.
The board issued shares, convertibles, and warrants to pay for property assets from Mofast and Frusipe Intressenter.
The properties are light warehouse and office, with annual rental income of SEK 21.6 mn and NOI yield of 6%.
Episurf Medical is diluted by 12 percent after convertibles, linked to a previous acquisition, of 37.5 million kronor have been converted into shares.
The medical technology company Episurf, where Ilija Batljan is a major owner, continues its rapid expansion in the real estate market. Episurf (stock price Episurf) acquires all shares in Kuststaden Invest AB, incl...
Episurf, with Ilija Batljan as major shareholder, buys 30 properties for 920 million kronor from Livi Fastigheter – while criticism grows.
Episurf Medical's board has decided to issue B-shares, convertibles and warrants as part of the payment for the company's acquisition of real estate assets. This appears from a...
Track Episurf Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.